Buerger's Disease Market Size
Market Size in USD Mn
CAGR5.4%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 5.4% |
| Market Concentration | High |
| Major Players | AnGes Inc., Mitsubishi Tanabe Pharma Corporation, Pluristem Therapeutics Inc., Stempeutics Research Pvt. Ltd., Fuji Yakuhin Co., Ltd. and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Buerger's Disease Market Analysis
The Buerger's disease market is estimated to be valued at USD 443.7 million in 2025 and is expected to reach USD 641.2 million by 2032, growing at a compound annual growth rate (CAGR) of 5.4% from 2025 to 2032. With increasing awareness about the symptoms and risk factors, a greater number of patients are being diagnosed annually. Along with this, the availability of various treatment options and new drugs in the pipeline will contribute to the growth of the market during the forecast period.